Compagnie Lombard Odier SCmA’s ARK Genomic Revolution ETF ARKG Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.19K	Hold	310	–	–	﹤0.01%	390
2025 Q4	$8.98K	Hold	310	–	–	﹤0.01%	390
2025 Q3	$8.61K	Hold	310	–	–	﹤0.01%	409
2025 Q2	$7.55K	Hold	310	–	–	﹤0.01%	397
2025 Q1	$6.44K	Hold	310	–	–	﹤0.01%	438
2024 Q4	$7.3K	Hold	310	–	–	﹤0.01%	415
2024 Q3	$7.94K	Hold	310	–	–	﹤0.01%	410
2024 Q2	$7.28K	Hold	310	–	–	﹤0.01%	401
2024 Q1	$8.92K	Hold	310	–	–	﹤0.01%	430
2023 Q4	$10.2K	Hold	310	–	–	﹤0.01%	491
2023 Q3	$8.64K	Hold	310	–	–	﹤0.01%	521
2023 Q2	$10.6K	Hold	310	–	–	﹤0.01%	500
2023 Q1	$9.32K	Hold	310	–	–	﹤0.01%	556
2022 Q4	$9K	Hold	310	–	–	﹤0.01%	610
2022 Q3	$10K	Sell	310 -1,434	-82%	-$52.6K	﹤0.01%	570
2022 Q2	$56K	Hold	1,744	–	–	﹤0.01%	426
2022 Q1	$79K	Sell	1,744 -1,003	-37%	-$47.8K	﹤0.01%	402
2021 Q4	$168K	Sell	2,747 -445	-14%	-$30.8K	﹤0.01%	388
2021 Q3	$238K	Sell	3,192 -1,000	-24%	-$83.9K	0.01%	331
2021 Q2	$389K	Sell	4,192 -4,428	-51%	-$376K	0.01%	263
2021 Q1	$765K	Buy	8,620 +6,420	+292%	+$637K	0.02%	235
2020 Q4	$205K	Buy	2,200 +1,200	+120%	+$95.6K	0.01%	329
2020 Q3	$64K	Buy	+1,000	New	+$58.6K	﹤0.01%	373
2018 Q4	–	Sell	-1,500	Closed	-$50K	–	550
2018 Q3	$50K	Buy	+1,500	New	+$47.5K	﹤0.01%	424

Other funds holding ARKG

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Compagnie Lombard Odier SCmA's ARKG Position: Q1 2026 in Review

Compagnie Lombard Odier SCmA held its ARK Genomic Revolution ETF (ARKG) position steady in Q1 2026 at 310 shares worth $8.19K. The position accounts for ﹤0.01% of the portfolio, ranked #390.

Compagnie Lombard Odier SCmA first reported a position in ARKG in Q3 2018 and has held it in 24 quarters since. The position peaked at $765K in Q1 2021. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

Compagnie Lombard Odier SCmA held 310 shares of ARK Genomic Revolution ETF worth $8.19K as of Q1 2026.
Compagnie Lombard Odier SCmA left its ARK Genomic Revolution ETF share count unchanged in Q1 2026.
ARK Genomic Revolution ETF made up ﹤0.01% of Compagnie Lombard Odier SCmA's portfolio in Q1 2026, its #390 holding.
Compagnie Lombard Odier SCmA first reported a position in ARK Genomic Revolution ETF in Q3 2018 and has held it in 24 quarters since.
Compagnie Lombard Odier SCmA's ARK Genomic Revolution ETF position peaked at $765K in Q1 2021.
218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2026, filed 15 Apr 2026.